These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 30171566)

  • 1. Antisense-Mediated Splice Modulation to Reframe Transcripts.
    Titeux M; Turczynski S; Pironon N; Hovnanian A
    Methods Mol Biol; 2018; 1828():531-552. PubMed ID: 30171566
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antisense-mediated exon skipping to reframe transcripts.
    Turczynski S; Titeux M; Pironon N; Hovnanian A
    Methods Mol Biol; 2012; 867():221-38. PubMed ID: 22454065
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Analysis of the functional consequences of targeted exon deletion in COL7A1 reveals prospects for dystrophic epidermolysis bullosa therapy.
    Bornert O; Kühl T; Bremer J; van den Akker PC; Pasmooij AM; Nyström A
    Mol Ther; 2016 Aug; 24(7):1302-11. PubMed ID: 27157667
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Targeted Exon Skipping Restores Type VII Collagen Expression and Anchoring Fibril Formation in an In Vivo RDEB Model.
    Turczynski S; Titeux M; Tonasso L; Décha A; Ishida-Yamamoto A; Hovnanian A
    J Invest Dermatol; 2016 Dec; 136(12):2387-2395. PubMed ID: 27498345
    [TBL] [Abstract][Full Text] [Related]  

  • 5. QR-313, an Antisense Oligonucleotide, Shows Therapeutic Efficacy for Treatment of Dominant and Recessive Dystrophic Epidermolysis Bullosa: A Preclinical Study.
    Bornert O; Hogervorst M; Nauroy P; Bischof J; Swildens J; Athanasiou I; Tufa SF; Keene DR; Kiritsi D; Hainzl S; Murauer EM; Marinkovich MP; Platenburg G; Hausser I; Wally V; Ritsema T; Koller U; Haisma EM; Nyström A
    J Invest Dermatol; 2021 Apr; 141(4):883-893.e6. PubMed ID: 32946877
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeted skipping of a single exon harboring a premature termination codon mutation: implications and potential for gene correction therapy for selective dystrophic epidermolysis bullosa patients.
    Goto M; Sawamura D; Nishie W; Sakai K; McMillan JR; Akiyama M; Shimizu H
    J Invest Dermatol; 2006 Dec; 126(12):2614-20. PubMed ID: 16778792
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Moderation of phenotypic severity in dystrophic and junctional forms of epidermolysis bullosa through in-frame skipping of exons containing non-sense or frameshift mutations.
    McGrath JA; Ashton GH; Mellerio JE; Salas-Alanis JC; Swensson O; McMillan JR; Eady RA
    J Invest Dermatol; 1999 Sep; 113(3):314-21. PubMed ID: 10469327
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nonsequential Splicing Events Alter Antisense-Mediated Exon Skipping Outcome in
    Ham KA; Aung-Htut MT; Fletcher S; Wilton SD
    Int J Mol Sci; 2020 Oct; 21(20):. PubMed ID: 33081018
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Splicing Modulation via Antisense Oligonucleotides in Recessive Dystrophic Epidermolysis Bullosa.
    Hainzl S; Trattner L; Liemberger B; Bischof J; Kocher T; Ablinger M; Nyström A; Obermayer A; Klausegger A; Guttmann-Gruber C; Wally V; Bauer JW; Hofbauer JP; Koller U
    Int J Mol Sci; 2024 Jan; 25(2):. PubMed ID: 38255836
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In Vitro Models for the Evaluation of Antisense Oligonucleotides in Skin.
    Bremer J; van den Akker PC
    Methods Mol Biol; 2022; 2434():185-190. PubMed ID: 35213017
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Compound heterozygosity for a recessive glycine substitution and a splice site mutation in the COL7A1 gene causes an unusually mild form of localized recessive dystrophic epidermolysis bullosa.
    Terracina M; Posteraro P; Schubert M; Sonego G; Atzori F; Zambruno G; Bruckner-Tuderman L; Castiglia D
    J Invest Dermatol; 1998 Nov; 111(5):744-50. PubMed ID: 9804332
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Personalized Development of Antisense Oligonucleotides for Exon Skipping Restores Type XVII Collagen Expression in Junctional Epidermolysis Bullosa.
    Ablinger M; Lettner T; Friedl N; Potocki H; Palmetzhofer T; Koller U; Illmer J; Liemberger B; Hainzl S; Klausegger A; Reisenberger M; Lambert J; Van Gele M; Desmet E; Van Maelsaeke E; Wimmer M; Zauner R; Bauer JW; Wally V
    Int J Mol Sci; 2021 Mar; 22(7):. PubMed ID: 33805154
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Splice site mutation in COL7A1 resulting in aberrant in-frame transcripts identified in a case of recessive dystrophic epidermolysis bullosa, pretibial.
    Masunaga T; Kubo A; Ishiko A
    J Dermatol; 2018 Jun; 45(6):742-745. PubMed ID: 29500833
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mutation analysis and characterization of COL7A1 mutations in dystrophic epidermolysis bullosa.
    Dang N; Murrell DF
    Exp Dermatol; 2008 Jul; 17(7):553-68. PubMed ID: 18558993
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In Vivo Models for the Evaluation of Antisense Oligonucleotides in Skin.
    Bremer J; van den Akker PC
    Methods Mol Biol; 2022; 2434():315-320. PubMed ID: 35213027
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Exon 87 skipping of the COL7A1 gene in dominant dystrophic epidermolysis bullosa.
    Koga H; Hamada T; Ishii N; Fukuda S; Sakaguchi S; Nakano H; Tamai K; Sawamura D; Hashimoto T
    J Dermatol; 2011 May; 38(5):489-92. PubMed ID: 21352278
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Deletions within COL7A1 exons distant from consensus splice sites alter splicing and produce shortened polypeptides in dominant dystrophic epidermolysis bullosa.
    Sakuntabhai A; Hammami-Hauasli N; Bodemer C; Rochat A; Prost C; Barrandon Y; de Prost Y; Lathrop M; Wojnarowska F; Bruckner-Tuderman L; Hovnanian A
    Am J Hum Genet; 1998 Sep; 63(3):737-48. PubMed ID: 9718359
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Seven novel COL7A1 mutations identified in patients with recessive dystrophic epidermolysis bullosa from Mexico.
    Saeidian AH; Youssefian L; Moreno Trevino MG; Fortuna G; Vahidnezhad H; Atanasova VS; Uitto J; Salas-Alanis JC; South AP
    Clin Exp Dermatol; 2018 Jul; 43(5):579-584. PubMed ID: 29473190
    [TBL] [Abstract][Full Text] [Related]  

  • 19. One Novel Frameshift Mutation on Exon 64 of COL7A1 Gene in an Iranian Individual Suffering Recessive Dystrophic Epidermolysis Bullosa.
    Khaniani MS; Sohrabi N; Derakhshan NM; Derakhshan SM
    Ann Clin Lab Sci; 2015; 45(5):582-4. PubMed ID: 26586712
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A COL7A1 variant leading to in-frame skipping of exon 15 attenuates disease severity in recessive dystrophic epidermolysis bullosa.
    Schwieger-Briel A; Weibel L; Chmel N; Leppert J; Kernland-Lang K; Grüninger G; Has C
    Br J Dermatol; 2015 Nov; 173(5):1308-11. PubMed ID: 26076072
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.